Future Enterprises [FELDVR] vs Astal Laboratories [ASTALLTD] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Future Enterprises Ltd. wins in 4 metrics, Astal Laboratories Ltd. wins in 13 metrics, with 0 ties. Astal Laboratories Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Future Enterprises Ltd. | Astal Laboratories Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -0.05 | 8.92 | Astal Laboratories Ltd. |
| Price-to-Book Ratio | 0.06 | 1.57 | Future Enterprises Ltd. |
| Debt-to-Equity Ratio | -28.41 | 29.18 | Astal Laboratories Ltd. |
| PEG Ratio | N/A | -0.66 | N/A |
| EV/EBITDA | -46.57 | 5.91 | Astal Laboratories Ltd. |
| Profit Margin (TTM) | -131.19% | 7.11% | Astal Laboratories Ltd. |
| Operating Margin (TTM) | -97.99% | 6.03% | Astal Laboratories Ltd. |
| EBITDA Margin (TTM) | N/A | 6.03% | N/A |
| Return on Equity | -238.27% | 24.80% | Astal Laboratories Ltd. |
| Return on Assets (TTM) | -5.11% | 14.09% | Astal Laboratories Ltd. |
| Free Cash Flow (TTM) | $3.90B | $-182.92M | Future Enterprises Ltd. |
| 1-Year Return | -31.58% | -8.03% | Astal Laboratories Ltd. |
| Price-to-Sales Ratio (TTM) | 0.07 | 1.95 | Future Enterprises Ltd. |
| Enterprise Value | $76.07B | $762.07M | Future Enterprises Ltd. |
| EV/Revenue Ratio | 3.47 | 0.55 | Astal Laboratories Ltd. |
| Gross Profit Margin (TTM) | -43.00% | 9.78% | Astal Laboratories Ltd. |
| Revenue per Share (TTM) | $46 | $135 | Astal Laboratories Ltd. |
| Earnings per Share (Diluted) | $-30.54 | $7.13 | Astal Laboratories Ltd. |
| Beta (Stock Volatility) | 0.27 | -0.55 | Astal Laboratories Ltd. |
Future Enterprises Ltd. vs Astal Laboratories Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Future Enterprises Ltd. | 4.62% | 4.62% | 2.26% | -3.89% | -15.79% | -13.38% |
| Astal Laboratories Ltd. | 4.96% | 13.85% | -0.82% | 12.34% | -6.74% | -7.93% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Future Enterprises Ltd. | -31.58% | -38.82% | -81.69% | -85.47% | -97.92% | -99.12% |
| Astal Laboratories Ltd. | -8.03% | 71.50% | 71.50% | 71.50% | 71.50% | 71.50% |
Performance & Financial Health Analysis: Future Enterprises Ltd. vs Astal Laboratories Ltd.
| Metric | FELDVR | ASTALLTD |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.49B | ₹2.68B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 4,402 | 43,550 |
| 90 Day Avg. Volume | 4,188 | 25,611 |
| Last Close | ₹2.72 | ₹81.11 |
| 52 Week Range | ₹2.35 - ₹3.90 | ₹60.45 - ₹103.20 |
| % from 52W High | -30.26% | -21.41% |
| All-Time High | ₹588.49 (Dec 31, 2007) | ₹131.70 (Sep 09, 2024) |
| % from All-Time High | -99.54% | -38.41% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.13% | 2.65% |
| Quarterly Earnings Growth | -0.13% | -0.05% |
| Financial Health | ||
| Profit Margin (TTM) | -1.31% | 0.07% |
| Operating Margin (TTM) | -0.98% | 0.06% |
| Return on Equity (TTM) | -2.38% | 0.25% |
| Debt to Equity (MRQ) | -28.41 | 29.18 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹52.91 | ₹40.48 |
| Cash per Share (MRQ) | ₹0.34 | ₹4.63 |
| Operating Cash Flow (TTM) | ₹4.00B | ₹-116,989,000 |
| Levered Free Cash Flow (TTM) | ₹13.64B | ₹89.25M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Future Enterprises Ltd. vs Astal Laboratories Ltd.
| Metric | FELDVR (Apr 24, 2026) | ASTALLTD (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -0.05 | 8.92 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | -0.66 |
| Price to Sales (TTM) | 0.07 | 1.95 |
| Price to Book (MRQ) | 0.06 | 1.57 |
| Market Capitalization | ||
| Market Capitalization | ₹1.49B | ₹2.68B |
| Enterprise Value | ₹76.07B | ₹762.07M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.47 | 0.55 |
| Enterprise to EBITDA | -46.57 | 5.91 |
| Risk & Other Metrics | ||
| Beta | 0.27 | -0.55 |
| Book Value per Share (MRQ) | ₹52.91 | ₹40.48 |
Financial Statements Comparison: Future Enterprises Ltd. vs Astal Laboratories Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | FELDVR (2022) | ASTALLTD (2025) |
|---|---|---|
| Revenue/Sales | 21.93B | 642.31M |
| Cost of Goods Sold | 20.27B | 484.81M |
| COGS % of Revenue | 92.4% | 75.5% |
| Gross Profit | 1.66B | 157.50M |
| Gross Margin | 7.6% | 24.5% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | -8.29B | 125.53M |
| Operating Margin | -37.8% | 19.5% |
| EBITDA | -3.45B | 129.01M |
| EBITDA Margin | -15.7% | 20.1% |
| Pre-Tax Income | -31.73B | 119.78M |
| Pre-Tax Income % of Revenue | -144.7% | 18.6% |
| Income Tax | 0 | 30.52M |
| Income Tax % of Revenue | 0.0% | 4.8% |
| Net Income (Profit) | -31.73B | 89.25M |
| Profit Margin | -144.7% | 13.9% |
Balance Sheet & Liquidity Metrics
| Metric | FELDVR (2022) | ASTALLTD (2025) |
|---|---|---|
| Cash & Equivalents | 64.40M | 17.30M |
| Total Current Assets | 30.32B | 456.39M |
| Total Current Assets % of Revenue | 138.2% | 71.1% |
| Total Current Liabilities | 82.76B | 267.71M |
| Total Current Liabilities % of Revenue | 377.3% | 41.7% |
| Long-Term Debt | 3.14B | 4.56M |
| Long-Term Debt % of Revenue | 14.3% | 0.7% |
| Total Shareholders Equity | -2.63B | 359.95M |
| Retained Earnings | N/A | 107.05M |
| Retained Earnings % of Revenue | 0.0% | 16.7% |
| Property, Plant & Equipment | 32.07B | 0 |
Cash Flow Statement Comparison
| Metric | FELDVR (2022) | ASTALLTD (2025) |
|---|---|---|
| Operating Cash Flow | -16.24B | -116.99M |
| Operating Cash Flow % of Revenue | -74.1% | -18.2% |
| Capital Expenditures | -100.30M | -57.75M |
| Free Cash Flow | 3.90B | -182.92M |
| FCF Margin | 17.8% | -28.5% |
| Debt Repayment | N/A | -547,000 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | FELDVR | ASTALLTD |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 494.31M | 42.22M |
| Float Shares | 322.98M | 5.68M |
| % Held by Insiders | 72.22% | 66.12% |
| % Held by Institutions | 0.00% | 0.00% |
| % Held by Public | 27.78% | 33.88% |
Dividend Analysis & Yield Comparison: Future Enterprises Ltd. vs Astal Laboratories Ltd.
| Metric | FELDVR | ASTALLTD |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.00 | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | ₹0.00 | N/A |
| Ex-Dividend Date | N/A | N/A |